WolkK, Join-LambertO, SabatR. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol, 2020; 183(6):999–1010.
2.
PatelK, LiuL, AhnB, et al.Hidradenitis suppurativa for the nondermatology clinician. Proc Bayl Univ Med Cent, 2020; 33(4):586–591.
3.
SachdevaM, MuftiA, ZaarouraH, et al.Squamous cell carcinoma arising within hidradenitis suppurativa: A literature review. Int J Dermatol, 2021; 60(11):e459–e465; doi: 10.1111/ijd.15677
4.
KridinK, AmberKT, ComaneshterD, et al.Amyloidosis in hidradenitis suppurativa: A cross-sectional study and review of the literature. Clin Exp Dermatol, 2020; 45(5):565–571.
5.
GargA, PapagermanosV, MiduraM, et al.Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States. J Am Acad Dermatol, 2018; 79(3):495–500.e1.
6.
ZouboulisCC, BenhadouF, ByrdAS, et al.What causes hidradenitis suppurativa?-15 years after. Exp Dermatol, 2020; 29(12):1154–1170.
7.
LyonsAB, ShabeebN, NicholsonCL, et al.Emerging medical treatments for hidradenitis suppurativa. J Am Acad Dermatol, 2020; 83(2):554–562.
8.
van StraalenKR, Schneider-BurrusS, PrensEP. Current and future treatment of hidradenitis suppurativa. Br J Dermatol, 2020; 183(6):e178–e187.
9.
ZouboulisCC, ReadheadB, DudleyJT. An additional drug repurposing study for hidradenitis suppurativa/acne inversa. Br J Dermatol, 2021; 184(4):748–750.
10.
OláhA, SzekaneczZ, BíróT. Targeting cannabinoid signaling in the immune system: “High”-ly exciting questions, possibilities, and challenges. Front Immunol, 2017; 8:1487.
11.
TóthKF, ÁdámD, BíróT, et al.Cannabinoid signaling in the skin: Therapeutic potential of the “C(ut)annabinoid” system. Mol Basel Switz, 2019; 24(5):E918.
12.
AppendinoG, GibbonsS, GianaA, et al.Antibacterial cannabinoids from Cannabis sativa: A structure-activity study. J Nat Prod, 2008; 71(8):1427–1430.
13.
MaidaV, ShiRB, FazzariFGT, et al.Topical cannabis-based medicines—A novel adjuvant treatment for venous leg ulcers: An open-label trial. Exp Dermatol, 2021; 30(9):1258–1267; doi: 10.1111/exd.14395
14.
OláhA, TóthBI, BorbíróI, et al.Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. J Clin Invest, 2014; 124(9):3713–3724.
15.
OláhA, MarkovicsA, Szabó-PappJ, et al.Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Exp Dermatol, 2016; 25(9):701–707.
16.
LesortC, VillaniAP, GiaiJ, et al.High prevalence of cannabis use among patients with hidradenitis suppurativa: Results from the VERADDICT survey. Br J Dermatol, 2019; 181(4):839–841.
